Ventyx Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Ventyx Biosciences

23/03/2023 21:01

* Ventyx Biosciences Inc  VTYX.OQ  reported a quarterly
adjusted
loss of 62 cents​​ per share for the quarter ended in December.
The mean expectation of eleven analysts for the quarter was
for a loss of 64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Ventyx Biosciences Inc's reported EPS for the quarter was
a loss
of 62 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Ventyx Biosciences Inc shares had risen by 15.1% this
quarter.
    * The company reported a quarterly loss of $35.21 million.
    * Wall Street's median 12-month price target for Ventyx
Biosciences Inc is $55.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 09:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.64          -0.62          Beat
 Sep. 30 2022      -0.44          -0.59          Missed
 Jun. 30 2022      -0.45          -0.39          Beat
 Mar. 31 2022      -0.52          -0.45          Beat